Loading...
Images of Mathias Oelke
(0 from 0 )1
0
0
News
Vierte "Church Night" in Eilshausen | nw.de
www.nw.de
Anders als gewohnt hat sich wieder einmal die Eilshauser Kirche präsentiert. Zum vierten Mal erstrahlte das Gebäude, ganz im Zeichen des Reformationsfestes...
Novel Approach to Adoptive Immunotherapy Developed by NexImmune's...
www.finanznachrichten.de
Dr. Mathias Oelke, Scientific Co-founder and Senior Director of Discovery at NexImmune and co-author on the publication, noted the broad ...
Magnetic Nanoparticles Found to Boost Immunotherapy | Science and...
sciencebusiness.technewslit.com
Researchers at Johns Hopkins University designed a process to collect cancer-fighting T-cells faster and easier with magnetic synthetic antigen nanoparticles.
NexImmune Announces $3 Million Financing | NEA | New Enterprise...
www.nea.com
... (AIM™) nanotechnology. The AIM technology, which was first developed by Drs. Mathias Oelke and Jonathan Schneck at The Johns Hopkins University, ...
Telephone & Addresses
Mathias Oelke, Parkville, US, Fieldcreek Way
View Mathias's social profiles and photos on Facebook, MySpace, and +40 Networks.
Mathias Oelke, Parkville, US, Rockberry Rd
View Mathias's social profiles and photos on Facebook, MySpace, and +40 Networks.
Mathias Oelke, 48, Parkville, US, Wilson Ave
View Mathias's social profiles and photos on Facebook, MySpace, and +40 Networks.
WhitePages: One result for Ulrike Oelke - People Search | Whitepages
Also known as Ulrike Schlichte Oelke, Ulrike Schlichte Oelke; Age 52; Lives in Parkville MD; Used to live in —; Related to Mathias Oelke. View Full Report.
Network Profiles
Protocols and Video Articles Authored by Mathias Oelke
www.jove.com
Mathias Oelke is the author of these articles in the Journal of Visualized Experiments:
Mathias Oelke, Senior Vice President of Preclinical Immunotherapy &...
relationshipscience.com
Mathias Oelke is Senior Vice President of Preclinical Immunotherapy & Head of Cell Biology at Neximmune, Inc. View Mathias Oelke’s professional profile on...
Interests
Magnetic nanoparticles could be key to effective immunotherapy |...
www.eurekalert.org
In recent years, researchers have hotly pursued immunotherapy, a promising form of treatment that relies on harnessing and training the body's own immune...
www.sciencedaily.com › releases › Technique Brings Immune-based Therapies Closer To Reality ...
www.sciencedaily.com
"But dendritic cells vary in quality and number from patient to patient," says first author Mathias Oelke, Ph.D., a postdoctoral fellow in pathology ...
Business Profiles
patentbuddy: Mathias Oelke
THE JOHNS HOPKINS UNIVERSITY, Baltimore, MD, US
ResearchGate
www.researchgate.net
ResearchGate is a network dedicated to science and research. Connect, collaborate and discover scientific publications, jobs and conferences. All for free.
Award Number: W81-XWH TITLE: …
www.researchgate.net
PRINCIPAL INVESTIGATOR: Mathias Oelke, Ph.D. CONTRACTING ORGANIZATION: Johns Hopkins University Baltimore, MD …
Books & Literature
PLOS Neglected Tropical Diseases: T-Cell Memory Responses Elicited by...
journals.plos.org
Author Summary T-cell responses are considered to be very important; however, the role of T-cell responses in vaccine mediated immunity is still controversial....
fachbuchquelle.de Weinbrenner Buch-Shop
drw-verlag.de
Reeg, Tatjana / Brix, Mathias / Oelke, Manuel / Konold, Werner Baumlandschaften Nutzen und Ästhetik von Bäumen in der offenen Landschaft Bäume kommen in der offenen Landschaft in unterschiedlichsten Formen vor. Meist haben sie eine bestimmte Funktion, und ihr Standort ist oft nicht zufällig. Dieses Buch zeigt ...
books.google.com › booksAACR Proceedings: Abstracts Google Books Result
books.google.com.ua
... Kim, Lauren Suarez, Emily Lu, Celine Walmacq, Daniel Dembrow, Juan Varela, Dan Bednárik, Kenneth Carter, Naimish Pandya, Kristi Jones, Mathias Oelke.
Related Documents
Artificial Antigen-Presenting Cells for Use in Adaptive Immunother.....
www.authorstream.com
Artificial Antigen-Presenting Cells for Use in Adaptive Immunother..- authorSTREAM Presentation
Award Number: W81-XWH TITLE: …
www.dtic.mil
TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in ... Mathias Oelke, Ph.D. CONTRACTING ORGANIZATION: …
Development of Artificial Antigen Presenting Cells for Prostate Cancer ...
www.dtic.mil
Immunotherapy. PRINCIPAL INVESTIGATOR: Jonathan P. Schneck, M.D., Ph.D. Mathias Oelke, Ph.D. CONTRACTING ORGANIZATION: Johns ...
EBSCOhost | | In vivo functional efficacy of tumor-specific...
web.a.ebscohost.com
Mathias Oelke · Jonathan P. Schneck. Received: 4 March Accepted: 27 May Published online: 18 June © Springer-Verlag Abstract Adoptive immunotherapy for treatment of can- cers and infectious diseases is often hampered by a high degree of variability in the final T cell product and in the.
Scientific Publications
Clinical Immunology | Analysis of Immune Function Using Flow...
www.sciencedirect.com
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement. Original research article: Pages Mathias Oelke, Jonathan P Schneck. Download PDF. Article preview ...
Publications
Decline of influenza-specific CD8+ T cell repertoire in healthy...
core.ac.uk
By Jessica B Lee, Mathias Oelke, Lakshmi Ramachandra, David H Canaday and Jonathan P Schneck
Publications Authored by Jonathan …
www.pubfacts.com
Mathias Oelke, Jonathan Schneck; Rambam Maimonides Med J Jan 29;6(1):e Epub Jan 29. Department of Biomedical Engineering, Johns Hopkins School of ...
Decline of influenza-specific CD8 + T cell repertoire in healthy...
link.springer.com
Background While influenza vaccination results in protective antibodies against primary infections, clearance of infection is primarily mediated through CD8+ T...
Table of contents for Human immunology
catdir.loc.gov
Table of Contents for Human immunology : patient-based research / edited by Ralph M. Steinman, available from the Library of Congress.
Reports & Statements
Ex vivo induction and expansion of antigen-specific cytotoxic T cells...
www.nature.com
On the Market
Miscellaneous
Mathias Oelke | LinkedIn
www.linkedin.com
View Mathias Oelke’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Mathias Oelke discover inside ...
US A1 - Reagents and Methods for Engaging Unique Clonotypic...
patents.google.com
Platforms comprising at least one lymphocyte affecting molecule and at least one molecular complex that, when bound to an antigen, engages a unique...
CA C - Reagents and methods for engaging unique clonotypic...
patents.google.com
Inventors, Jonathan Schneck, Mathias Oelke. Applicant, The Johns Hopkins University, Jonathan Schneck, Mathias Oelke. Export Citation, BiBTeX, EndNote, ...
finance.yahoo.com › news › novel-approach-adoptive-immunotherapy-...Novel Approach to Adoptive Immunotherapy Developed by ...
finance.yahoo.com
Dr. Mathias Oelke, Scientific Co-founder and Senior Director of Discovery at NexImmune and co-author on the publication, noted the broad ...
NexImmune Appoints Kenneth Carter, PhD, as Yahoo Finance
finance.yahoo.com
· From Yahoo Finance: GAITHERSBURG, MD-- - NexImmune, ... developed by Dr. Mathias Oelke and Dr. Schneck's laboratory from The Johns Hopkins …
Öffnungszeiten - Dr. med. Mathias Oelke, Herford, Schwarzenmoorstraße...
aktuelle-oeffnungszeiten.com
Öffnungszeiten von Dr. med. Mathias OelkeHerford. Es stehen leider keine Öffnungszeiten zur Verfügung.
drug-dev.com › neximmune-acquired-by-a-consortium-of-private-inves...NexImmune Acquired by a Consortium of Private Investors ...
drug-dev.com
NexImmune's AIM technology, originally developed by Dr. Jonathan Schneck and Dr. Mathias Oelke at the Johns Hopkins School of Medicine, was licensed ...
Award Number: W81-XWH TITLE: Development …
www.dtic.mil
Mathias Oelke, Ph.D. 5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION …
AME » Blog Archive » Rambam Maimonides Medical Journal - Moked
moked.it
Adoptive T Cell Immunotherapy For Cancer Karlo Perica, Juan Carlos Varela, Mathias Oelke, and Jonathan Schneck. Clinical Research in Oncology The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian Carcinoma Joseph Menczer, Erez Ben-Shem, Abraham Golan, ...
Just a moment...
www.jimmunol.org
Ananta Paine, Hartmut Kirchner, Stephan Immenschuh, Mathias Oelke, Rainer Blasczyk and Britta Eiz-Vesper. J Immunol January 13, 2012, ...
Artificial antigen-presenting cells: Artificial solutions for real...
jhu.pure.elsevier.com
Artificial antigen-presenting cells: Artificial solutions for real diseases. Mathias Oelke, Christine Krueger, Robert L. Giuntoli, Jonathan P. Schneck · School of Medicine. Research output: Contribution to journal › Article ...
Former Celgene and Medtronic CEOs Just Acquired This Maryland Biotech...
www.biospace.com
Former Celgene and Medtronic CEOs Just Acquired This Maryland Biotech - read this article along with other careers information, tips and advice on BioSpace
NexImmune Appoints Kenneth Carter, PhD, as President and CEO and...
www.biospace.com
NexImmune Appoints Kenneth Carter, PhD, as President and CEO and Jonathan Schneck, MD, PhD as Chairman of Clinical and Scientific Advisory Board - read this...
JCI - Sprouty-2 regulates HIV-specific T cell polyfunctionality
www.jci.org
Yen-Ling Chiu,1,2,3,4 Liang Shan,2 Hailiang Huang,5 Carl Haupt,1,2,3 Catherine Bessell,1,2,3 David H. Canaday,6,7 Hao Zhang,8 Ya-Chi Ho,2 Jonathan D. Powell,9Mathias Oelke,1,2,3 Joseph B. Margolick,8 Joel N. Blankson,2 Diane E. Griffin,8 and Jonathan P. Schneck1,2,3. 1Department of Pathology ...
Journals on the Web
journals.prous.com
Volume 41, Issue 1, January 2005, Pages Second-generation antipsychotic medications in the treatment of mood disorders: Focus on aripiprazole Peter F. Buckley Full Article (37 KB) PDF (84 KB) Summary. Technological advances in adoptive immunotherapy Mathias Oelke, Christine Krueger and Jonathan P.
PLOS Neglected Tropical Diseases: Publishing science, accelerating...
journals.plos.org
Andréa Barbosa de Melo, Eduardo J. M. Nascimento, Ulisses Braga-Neto, Rafael Dhalia, Ana Maria Silva, Mathias Oelke, Jonathan P. Schneck, John Sidney, ...
Researchers find how ovarian tumor affects immune system | Washington...
www.washingtonexaminer.com
New clues about how the ovarian cancer tumor works to evade the body’s immune system could offer new leads for treatment and early diagnosis, Johns Hopkins...
Page 5
www.mededirect.org
Mathias Oelke, PhD, on behalf of a research group from Hannover Medical School, Hannover, Germany, presented the results of this study to the annual ...
The Johns Hopkins Gazette: May 5, 2003
pages.jh.edu
Johns Hopkins Gazette is
a weekly publication of the Johns Hopkins University.
manuscript abstract | Rambam Maimonides Medical Journal
www.rmmj.org.il
Karlo Perica, Juan Carlos Varela, Mathias Oelke, and Jonathan Schneck. Abstract. Harnessing the immune system to recognize and destroy ...
Related search requests for Mathias Oelke
| Christine Krueger Kenneth Carter Jonathan Schneck |
People Forename "Mathias" (6970) Name "Oelke" (155) |
sorted by relevance / date